Oncolytics Biotech Inc (ONCY): Total Assets
$7.58M
As of 2025-12-31
$7.67M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.58M | -43.5% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $13.42M | n/a | 2026-03-30, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | $7.58M | -43.5% |
| Rocket One Inc. (RKTO) | 2025-12-31 | $7.60M | -1.4% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| Acurx Pharmaceuticals, Inc. (ACXP) | 2025-12-31 | $7.69M | +99.3% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $7.45M | +33.1% |
| Processa Pharmaceuticals, Inc. (PCSA) | 2025-12-31 | $7.81M | +142.0% |
| Telomir Pharmaceuticals, Inc. (TELO) | 2025-12-31 | $7.34M | +454.5% |
| Dermata Therapeutics, Inc. (DRMA) | 2025-12-31 | $7.86M | +122.5% |
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $7.21M | -43.0% |
Compare ONCY, RKTO, SILO, ACXP side by side · Screen every company in Pharmaceutical Preparations ↗